The Italian Pharmacovigilance Program: An Observational Study of Adverse Effects of Natalizumab in Multiple Sclerosis Therapy
Giacoppo S, Ruscica M, Grimaldi LM, Bramanti P,
The following content is accessible for members only, please sign in.
Loading…